Converting the maybes: Crucial for a successful COVID-19 vaccination strategy
- PMID: 33471821
- PMCID: PMC7817004
- DOI: 10.1371/journal.pone.0245907
Converting the maybes: Crucial for a successful COVID-19 vaccination strategy
Abstract
Background: Broad community acceptance of a COVID-19 vaccination will be critical for effectively halting the spread of the virus. In this study, we focus on factors that differentiate those who are undecided from those who are either willing or unwilling to accept a prospective COVID-19 vaccine.
Methods: An online survey in May 2020 assessed Australian adults' willingness to receive a COVID-19 vaccine (yes, maybe, no). A multinomial logistical regression of responses (N = 1,313) was used to identify correlates of vaccine willingness between the three groups.
Results: 65% were willing to vaccinate, with 27% being in the 'maybe' category. Respondents were more likely to be in the 'maybe' than the 'yes' group when they perceived COVID-19 to be less severe, had less trust in science, were less willing to vaccinate for influenza, and were female. They were more likely to be in the 'maybe' than 'no' group when they perceived COVID-19 as severe, and less likely to be a hoax, had more trust in science, and greater willingness to vaccinate for influenza. A repeat of the survey in November 2020 with a subset of participants found fewer of them saying yes to the vaccine (56%) and more saying maybe (31%).
Conclusions: The effectiveness of any COVID-19 vaccine rollout will be reliant on maximizing uptake. The significant number of people who remain undecided about whether or not to get a COVID-19 vaccine, despite the ongoing devastating consequences of the virus for individuals, communities, and economies, is concerning. Our findings aid current research seeking to inform policy regarding how to convince the undecided to vaccinate.
Conflict of interest statement
Katie Attwell has previously been employed by the Immunisation Alliance of Western Australia to conduct social research using an unrestricted grant from Sanofi Pasteur. She has received travel, accommodation and conference registration support from GSK, and travel, accommodation, and Response to Reviewers speaker fees from Merck. She is currently in receipt of an Australian Research Council Discovery Early Career Researcher Award from the Australian Government, DE190100158. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors have no conflict to declare.
Figures
Similar articles
-
COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation.Yale J Biol Med. 2022 Jun 30;95(2):199-205. eCollection 2022 Jun. Yale J Biol Med. 2022. PMID: 35782475 Free PMC article.
-
Willingness of Greek general population to get a COVID-19 vaccine.Glob Health Res Policy. 2021 Jan 29;6(1):3. doi: 10.1186/s41256-021-00188-1. Glob Health Res Policy. 2021. PMID: 33509291 Free PMC article.
-
Understanding the societal factors of vaccine acceptance and hesitancy: evidence from Hong Kong.Public Health. 2022 Jun;207:39-45. doi: 10.1016/j.puhe.2022.03.013. Epub 2022 Apr 26. Public Health. 2022. PMID: 35486982 Free PMC article.
-
COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.Eur J Epidemiol. 2021 Feb;36(2):197-211. doi: 10.1007/s10654-021-00728-6. Epub 2021 Mar 1. Eur J Epidemiol. 2021. PMID: 33649879 Free PMC article.
-
Acceptance of the COVID-19 vaccine based on the health belief model: a multicenter national survey among medical care workers in China.Hum Vaccin Immunother. 2022 Nov 30;18(5):2076523. doi: 10.1080/21645515.2022.2076523. Epub 2022 May 18. Hum Vaccin Immunother. 2022. PMID: 35583502 Free PMC article.
Cited by
-
Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2021 Sep 24;9(10):1071. doi: 10.3390/vaccines9101071. Vaccines (Basel). 2021. PMID: 34696179 Free PMC article. Review.
-
Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.BMJ Open. 2021 Jun 30;11(6):e049356. doi: 10.1136/bmjopen-2021-049356. BMJ Open. 2021. PMID: 34193501 Free PMC article.
-
Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia.Vaccines (Basel). 2022 Oct 17;10(10):1730. doi: 10.3390/vaccines10101730. Vaccines (Basel). 2022. PMID: 36298595 Free PMC article.
-
Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance.Front Med (Lausanne). 2022 Jan 27;8:783982. doi: 10.3389/fmed.2021.783982. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155467 Free PMC article.
-
Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach.PLoS One. 2022 Jun 14;17(6):e0269059. doi: 10.1371/journal.pone.0269059. eCollection 2022. PLoS One. 2022. PMID: 35700197 Free PMC article.
References
-
- World Health Organisation. Landscape of COVID-19 candidate vaccines– 12 November 2020. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand...; 2020 [accessed 17 November 2020].
-
- Australian Government: Department of Health. Australia’s vaccine agreements. Available from: https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/abo...; 2020 [accessed 18 December 2020].
-
- Smith DT, Attwell K, Evers U. Majority acceptance of vaccination and mandates across the political spectrum in Australia. Politics. 2019; 40(2): 189–207. 10.1177/0263395719859457 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical